This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Converse, J. L. Articles by Snyder, E. M. Search for Related Content PubMed PubMed Citation Articles by Converse, J. L. Articles by Snyder, E. M.

 Previous Article  |  Next Article 

J Bacteriol. 1963 November; 86(5): 1041-1051
Copyright © 1963, The Williams & Wilkins Company. All Rights Reserved.

EXPERIMENTAL VIABLE VACCINE AGAINST PULMONARY COCCIDIOIDOMYCOSIS IN MONKEYS¹

^a U.S. Army Biological Laboratories, Fort Detrick, Frederick, Maryland

ABSTRACT

CONVERSE, JOHN L. (U.S. Army Biological Laboratories, Fort Detrick, Frederick, Md.), MERIDA W. CASTLEBERRY, AND ERNEST M. SNYDER. Experimental viable vaccine against pulmonary coccidioidomycosis in monkeys. J. Bacteriol. 86:1041–1051. 1963.—Monkeys (Macaca mulatta) vaccinated by subcutaneous injection in the forearm with from 10 to 10⁸ viable Coccidioides immitis arthrospores were protected against respiratory challenge with approximately 7000 viable arthrospores administered 6 months after vaccination. Protection was evident from: the healthy appearance throughout 4 months after respiratory challenge; negative chest X rays at 15, 30, 60, and 120 days; and only very minor histopathological pulmonary changes on autopsy at 120 days, with negative lung cultures in 80% of the animals. This was in striking contrast to the outward clinical appearance of control monkeys that were unvaccinated or had received nonviable arthrospore vaccines. These monkeys showed severe disease (loss of weight, accelerated respiration, severe coughing, general debilitation), positive X rays, massive pulmonary destruction, positive lung cultures, and death of five of nine animals. The appearance of spherules (very few in number, accompanied by very minor pathological changes) in the lungs of some of the "dissemination controls" (subcutaneous viable vaccination without respiratory challenge) indicated possible dissemination from the primary cutaneous infection, although oral transmission from the cutaneous lesions could not be ruled out.

² Present address: Research and Nutrition Laboratory, Fitzsimmons U.S. Army General Hospital, Denver, Colo.

¹ Animals maintained in compliance with the "Principles of Laboratory Animal Care" as promulgated by the National Society for Medical Research, 1961, Bio-Medical Purview 1:14.

This article has been cited by other articles:

• Cox, R. A., Magee, D. M. (2004). Coccidioidomycosis: Host Response and Vaccine Development. Clin. Microbiol. Rev. 17: 804-839 [Abstract] [Full Text]